Skip to main content

Day: March 27, 2024

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026 Executed private placement financing of up to $185 million, including initial upfront investment of $115.6 million; expected to extend cash runway into 2027 Webcast to be held tomorrow, March 28, 2024 at 8:30 a.m. E.T.WAYNE, Pa. and ROCKVILLE, Md., March 27, 2024 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced it has acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio, Inc. Concurrent with the acquisition, Avalo entered into a definitive agreement for the sale of preferred stock and warrants in a private placement led by Commodore Capital and TCGX,...

Continue reading

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Phase 2/3 Orbit Study and Phase 3 Cosmic Study of setrusumab in Osteogenesis Imperfecta expected to complete enrollment around the end of first quarter and in the first half of 2024, respectively Partnering discussions for alvelestat progressing with plans to initiate Phase 3 with a partner around the end of 2024 Cash of $57.4 million as of December 31, 2023 expected to fund operations into 2026 LONDON, March 27, 2024 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the full year ended December 31, 2023, and provided an update on recent corporate highlights. “We reached a number of important milestones in 2023, which have set the stage for a potentially transformative 2024,” said...

Continue reading

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results

Gained global registrational clarity for naporafenib and achieved key clinical milestones for naporafenib, ERAS-007, and ERAS-801 Multiple data readouts expected in 2024 for naporafenib (SEACRAFT-1), ERAS-007 (HERKULES-3), and ERAS-801 (THUNDERBBOLT-1) and planned initiation of pivotal SEACRAFT-2 trial Robust balance sheet with cash, cash equivalents, and marketable securities of $322 million as of December 31, 2023 Erasca to host R&D update conference call and webcast Thursday, March 28, 2024 at 8:30 am ET SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today provided business updates and reported financial results for the fiscal...

Continue reading

Universal Stainless to Webcast Fourth Quarter and Full Year 2023 Results Conference Call on March 28th

BRIDGEVILLE, Pa., March 27, 2024 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that it will report financial results for the fourth quarter and full year 2023 on Thursday, March 28, 2024. In conjunction with the earnings release, the Company will host a conference call at 10:00 a.m. (Eastern) on March 28th. The call will be webcast simultaneously for all interested parties. Call Dial-In Procedures: Please Click Here to register for the conference call and obtain your dial-in number and personal PIN number in advance of the call. The simultaneous webcast will be available on the Company’s website at www.univstainless.com, and thereafter archived on the website through the end of the second quarter of 2024. Please allow 5 minutes prior to the live webcast to visit the site to download...

Continue reading

Beacon Behavioral Partners Expands to Florida with the Addition of The Neuropsychiatry & TMS Group

The network of physician-driven psychiatric practices continues to expand across the Southeastern United States to enhance patient care BATON ROUGE, La., March 27, 2024 (GLOBE NEWSWIRE) — Beacon Behavioral Partners, a leading provider of support services for behavioral health practices, announced the acquisition of The Neuropsychiatry & TMS Group, a distinguished outpatient mental health provider in Tampa, Florida. This new alliance marks Beacon’s inaugural partnership in Florida, reflecting its goal to grow a network of reputable behavioral health practitioners devoted to enhancing patient care. “We are thrilled to have joined Beacon Behavioral Partners and expand throughout the state,” says Dr. Faizi Ahmed, the leading physician at Neuropsychiatry and TMS Group. “In our search for a partner, we met...

Continue reading

Stryve Foods, Inc. Announces Timing of Fiscal Year 2023 Results

PLANO, Texas, March 27, 2024 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), an emerging healthy snack and eating platform disrupting traditional consumer packaged goods (CPG) categories, and a leader in the air-dried meat snack industry in the United States, today announces that it will release its fiscal year 2023 results on Monday, April 1, 2024, after the market closes. In conjunction with the release, the Company has scheduled a conference call that will be hosted at 4:30 pm EDT Monday, April 1, 2024.By Phone:  Dial 1-888-886-7786 or 1-416-764-8658 at least 10 minutes before the call and ask to be joined into the Stryve call. A replay will be available through November 28, 2023, by dialing 1-844-512-2921 and using the replay PIN number: 96156137#.By Webcast: Connect to the webcast via...

Continue reading

LGI Homes Awarded Prestigious 2-10 Home Buyers Warranty Platinum Builder Award for Outstanding Leadership in New Construction

LGI Homes Awarded Prestigious 2-10 Home Buyers Warranty Platinum Builder AwardLGI Homes receives their sixth consecutive Platinum Builder Award, by 2-10 Home Buyers Warranty, in recognition of their exceptional leadership, innovation, and excellence in new construction.THE WOODLANDS, Texas, March 27, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH), one of the nation’s largest and most recognized homebuilders, announced today that they have been awarded the prestigious Platinum Builder Award by 2-10 Home Buyers Warranty, recognizing their exceptional leadership, innovation, and excellence in new construction throughout 2023. This marks the Company’s sixth consecutive year securing this accolade. LGI Homes’ commitment to quality, craftsmanship, and customer satisfaction has set a high standard throughout the industry,...

Continue reading

Verizon offers soccer fans the chance to attend LALIGA “ElClásico” in Spain

Social media sweepstakes #SorteoDeElClásico will send lucky winners to Spain for a VIP experience at the FC Barcelona vs Real Madrid match NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) — As part of Verizon’s ongoing partnership with LALIGA, starting today through April 2, Verizon is inviting soccer fans to participate in the sweepstakes #SorteoDeElClásico on the brand’s @TuVerizon Instagram for a chance to win a VIP LALIGA experience to “ElClásico”, the FC Barcelona vs Real Madrid match on April 21, 2024 at the Santiago Bernabeu Stadium in Madrid, Spain¹. The grand prize includes a VIP LALIGA experience with tickets to the “ElClásico” game for two winners + a guest, including round-trip airfare for two, hotel accommodations, transfers, stadium tours, goodie bags and more. There’s no purchase necessary to enter or win. The #SorteoDeElClásico...

Continue reading

ArcelorMittal announces publication of the 2023 statutory financial statements of ArcelorMittal parent company

27 March 2024, 20:15 CET ArcelorMittal has published the statutory financial statements of ArcelorMittal parent company for the year ended 31 December 2023. These financial statements have been filed with the electronic database of the Luxembourg Stock Exchange (www.bourse.lu) and are available on http://corporate.arcelormittal.com in the Corporate Library. ENDS About ArcelorMittal ArcelorMittal is one of the world’s leading integrated steel and mining companies with a presence in 60 countries and primary steelmaking operations in 15 countries. It is the largest steel producer in Europe, among the largest in the Americas, and has a growing presence in Asia through its joint venture AM/NS India. ArcelorMittal sells its products to a diverse range of customers including the automotive, engineering, construction and machinery industries,...

Continue reading

TowneBank Announces Retirement of Two Directors

SUFFOLK, Va., March 27, 2024 (GLOBE NEWSWIRE) — TowneBank (Nasdaq: TOWN) announced today that two long-serving members of its Board of Directors, Jacqueline B. Amato and Bradford L. Cherry, will step down from the Board and move to Emeritus status following the 2024 Annual Meeting of Shareholders.   Cherry is a founding director of TowneBank, having served as a director since TowneBank’s opening in 1999.   Amato joined TowneBank in 2000 to lead its successful entry into the residential mortgage lending business and was appointed to the Board that same year. “Jackie and Brad have made an extraordinary contribution to the growth and success of TowneBank,” said G. Robert Aston, Jr., TowneBank’s Executive Chairman.   “And while they may be stepping down from their roles as corporate directors, they will certainly not be stepping back...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.